Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000041822

Selleck Chemical LLC Dehydroaripiprazole E7427-5MG
SDP

Catalog No. 5000041822
Encompass_Preferred

Dehydroaripiprazole is the active metabolite of aripiprazole primarily metabolized by CYP3A4 and CYP2D6 It inhibits glutamate release from rat prefrontocortical nerve terminals by activating dopamine D2 and 5-HT1A receptors reducing nerve terminal excitability and VDCC activation through a PKA-mediated signaling cascade potentially contributing to its neuroprotective effects in excitotoxic injury

Catalog No. 50-000-41822 Supplier Selleck Chemical LLC Supplier No. E74275MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Dehydroaripiprazole is the active metabolite of aripiprazole primarily metabolized by CYP3A4 and CYP2D6 It inhibits glutamate release from rat prefrontocortical nerve terminals by activating dopamine D2 and 5-HT1A receptors reducing nerve terminal excitability and VDCC activation through a PKA-mediated signaling cascade potentially contributing to its neuroprotective effects in excitotoxic injury

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.